Reference number : GC-2017-Q2-00436, amendment number : , agreement type : G, recipient legal name : Puri, Ishwar (McMaster University), recipient country : CA, recipient province : nan, recipient city : Ontario, recipient postal code : nan, program name english : Engage Grants for Universities, program name french : Subventions d'engagement partenarial pour les universités, program purpose english : Organ shortage is an ever pressing issue facing patients today. In the year 2014, organ transplant surgeries_x000D_
amounted for 2,356, yet more than 4,500 Canadians remained without their much needed organ transplants by_x000D_
the end of that year. 238 patients have succumbed to their respective organ failure as a result of organ donor_x000D_
shortage (Source: Canadian Institute for Health Information, Canada). At the forefront of cutting-edge research_x000D_
are 3D bioprinters. These machines allow for the creation of 3D cellular structures, better mimicking those_x000D_
found in our bodies, and thus synthetically fabricate functional organs, which may solve today's organ shortage_x000D_
problem. While simplistic cellular constructs are possible, more complex organs remain just outside the reach_x000D_
of applied science. The wide adoption of bioprinters, however, is currently hindered by their high price._x000D_
Structur3D Printing, a Waterloo based company, has focused on offering robust and economical 3D printing_x000D_
platforms, which can accommodate various printable inks. By expanding the spectrum of ink to include_x000D_
bioinks, more economical bioprinting platforms will become possible. Therefore, Structur3D Printing proposes_x000D_
a partnership with McMaster University. The scope of the proposed project is to develop a rapid bioink_x000D_
manufacturing methodology using contactless magnetic manipulation of cells to create 3D cell spheroids,_x000D_
which will be used as the building blocks in the bioink development phase. The project and technology will_x000D_
allow the company to develop a proof of concept of rapid bioink fabrication and their subsequent use with a_x000D_
cost effective 3D printer to print functioning 3D cellular structures, thereby facilitating the adoption of_x000D_
bioprinters and accelerating research in the drug screening and tissue engineering fields. Providing Structur3d_x000D_
3D Printing with a solution to their problem will help to further position Canada at the forefront of 3D_x000D_
bioprinting innovation globally._x000D_
For more information on Structur3D Printing, please visit: https://www.structur3d.io/, program purpose french : Organ shortage is an ever pressing issue facing patients today. In the year 2014, organ transplant surgeries_x000D_
amounted for 2,356, yet more than 4,500 Canadians remained without their much needed organ transplants by_x000D_
the end of that year. 238 patients have succumbed to their respective organ failure as a result of organ donor_x000D_
shortage (Source: Canadian Institute for Health Information, Canada). At the forefront of cutting-edge research_x000D_
are 3D bioprinters. These machines allow for the creation of 3D cellular structures, better mimicking those_x000D_
found in our bodies, and thus synthetically fabricate functional organs, which may solve today's organ shortage_x000D_
problem. While simplistic cellular constructs are possible, more complex organs remain just outside the reach_x000D_
of applied science. The wide adoption of bioprinters, however, is currently hindered by their high price._x000D_
Structur3D Printing, a Waterloo based company, has focused on offering robust and economical 3D printing_x000D_
platforms, which can accommodate various printable inks. By expanding the spectrum of ink to include_x000D_
bioinks, more economical bioprinting platforms will become possible. Therefore, Structur3D Printing proposes_x000D_
a partnership with McMaster University. The scope of the proposed project is to develop a rapid bioink_x000D_
manufacturing methodology using contactless magnetic manipulation of cells to create 3D cell spheroids,_x000D_
which will be used as the building blocks in the bioink development phase. The project and technology will_x000D_
allow the company to develop a proof of concept of rapid bioink fabrication and their subsequent use with a_x000D_
cost effective 3D printer to print functioning 3D cellular structures, thereby facilitating the adoption of_x000D_
bioprinters and accelerating research in the drug screening and tissue engineering fields. Providing Structur3d_x000D_
3D Printing with a solution to their problem will help to further position Canada at the forefront of 3D_x000D_
bioprinting innovation globally._x000D_
For more information on Structur3D Printing, please visit: https://www.structur3d.io/, agreement title english : Contactless Formation of 3D Cellular Structures for Economical Bioprinting, agreement title french : Contactless Formation of 3D Cellular Structures for Economical Bioprinting, agreement number : EGP, agreement value : 25000.0, agreement start date : 2017-08-23, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada